{"id":15048,"date":"2022-04-05T12:25:35","date_gmt":"2022-04-05T02:25:35","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?post_type=references&p=15048"},"modified":"2023-07-04T08:22:34","modified_gmt":"2023-07-03T22:22:34","slug":"%e0%a4%a1%e0%a4%bf%e0%a4%aa%e0%a5%8d%e0%a4%a5%e0%a5%80%e0%a4%b0%e0%a4%bf%e0%a4%af%e0%a4%be","status":"publish","type":"references","link":"https:\/\/mvec.mcri.edu.au\/hi\/references\/diphtheria\/","title":{"rendered":"\u0921\u093f\u092a\u094d\u0925\u0940\u0930\u093f\u092f\u093e"},"content":{"rendered":"
<\/p>\n

\u0907\u0928\u094d\u092b\u094d\u0932\u0941\u090f\u0902\u091c\u093e \u0915\u094d\u092f\u093e \u0939\u0948?<\/strong><\/h2>\n

Diphtheria is a rare but potentially life-threatening acute illness caused by the bacteria \u0915\u0949\u0930\u0940\u0928\u0947\u092c\u0948\u0915\u094d\u091f\u0940\u0930\u093f\u092f\u092e \u0921\u093f\u092a\u094d\u0925\u0940\u0930\u093f\u092f\u093e<\/em>. This bacteria can produce a potent toxin which causes serious disease. It mostly commonly causes an acute respiratory illness characterised by a \u201cpseudo membrane\u201d which forms over the pharyngeal area (throat).<\/p>\n

Other less common forms of illness caused by C. diphtheriae<\/em> include laryngeal\/tracheobronchial diphtheria, nasal diphtheria and cutaneous diphtheria.<\/p>\n

\u0915\u093f\u0928 \u0932\u0915\u094d\u0937\u0923\u094b\u0902 \u092a\u0930 \u0928\u095b\u0930 \u0930\u0916\u0928\u0947 \u0915\u0940 \u0906\u0935\u0936\u094d\u092f\u0915\u0924\u093e \u0939\u0948?<\/strong><\/h2>\n

The incubation period is 2-5 days. Early symptoms include low-grade fever, lethargy and malaise. Affected people may develop a sore throat, which may cause pain on swallowing or a hoarse voice.<\/p>\n

One to two days after symptom onset, a \u201cpseudo membrane\u201d develops in 95% of cases, which appears as a thick, grey and leathery membrane at the back of the throat. This is formed from cell debris and inflammatory exudate. Breathing difficulty may occur, especially if part of the membrane dislodges and obstructs the airway.<\/p>\n

Toxin-related complications include myocarditis (heart muscle inflammation), neuropathy (nerve damage) and in rare cases, acute tubular nephropathy (kidney damage).<\/p>\n

\u092f\u0939 \u0915\u0948\u0938\u0947 \u0938\u0902\u091a\u093e\u0930\u093f\u0924 \u0939\u094b\u0924\u093e \u0939\u0948?<\/strong><\/h2>\n

Diphtheria is very contagious and is spread by inhalation of respiratory droplets from an infected person. Diphtheria can also be spread via skin lesions, in cases of cutaneous diphtheria, and the bacteria can also survive on environmental surfaces for weeks.\u00a0 Asymptomatic carriers may transmit the bacteria.<\/p>\n

Humans are the only known reservoir for diphtheria.<\/p>\n

\u090f\u092a\u093f\u0921\u0947\u092e\u093f\u092f\u094b\u0932\u0949\u091c\u0940 (\u092e\u0939\u093e\u092e\u093e\u0930\u0940 \u0935\u093f\u091c\u094d\u091e\u093e\u0928)<\/h2>\n

In the pre-vaccine era, young children (< 10 years old) were at highest risk for contracting diphtheria. \u00a0Diphtheria previously represented one of the leading causes of death in childhood, with an associated mortality rate of 5-10%.<\/p>\n

Diphtheria is now rare in high income countries with high vaccination coverage, but remains endemic in many lower income countries. Outbreaks across the globe continue to be an issue, with 16,000 cases worldwide reported in 2018<\/a>.<\/p>\n

Cases in Australia are more commonly associated with the return of international travellers.<\/p>\n

\u0930\u094b\u0915\u0925\u093e\u092e\u0902<\/strong><\/h2>\n

Diphtheria is vaccine-preventable, with protection available through administration of combination vaccines routinely administered via the National Immunisation Program (NIP) at:<\/p>\n